• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为将证据转化为个体化医疗策略的工具的优势、劣势、机会和威胁分析(I-SWOT)。

Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).

作者信息

von Kodolitsch Yskert, Bernhardt Alexander M, Robinson Peter N, Kölbel Tilo, Reichenspurner Hermann, Debus Sebastian, Detter Christian

机构信息

German Aorta Centre of Hamburg, Centre of Cardiology and Cardiovascular Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin, Berlin, Germany.

出版信息

Aorta (Stamford). 2015 Jun 1;3(3):98-107. doi: 10.12945/j.aorta.2015.14.064. eCollection 2015 Jun.

DOI:10.12945/j.aorta.2015.14.064
PMID:27069939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4820345/
Abstract

BACKGROUND

It is the physicians' task to translate evidence and guidelines into medical strategies for individual patients. Until today, however, there is no formal tool that is instrumental to perform this translation.

METHODS

We introduce the analysis of strengths (S) and weaknesses (W) related to therapy with opportunities (O) and threats (T) related to individual patients as a tool to establish an individualized (I) medical strategy (I-SWOT). The I-SWOT matrix identifies four fundamental types of strategy. These comprise "SO" maximizing strengths and opportunities, "WT" minimizing weaknesses and threats, "WO" minimizing weaknesses and maximizing opportunities, and "ST" maximizing strengths and minimizing threats. Each distinct type of strategy may be considered for individualized medical strategies.

RESULTS

We describe four steps of I-SWOT to establish an individualized medical strategy to treat aortic disease. In the first step, we define the goal of therapy and identify all evidence-based therapeutic options. In a second step, we assess strengths and weaknesses of each therapeutic option in a SW matrix form. In a third step, we assess opportunities and threats related to the individual patient, and in a final step, we use the I-SWOT matrix to establish an individualized medical strategy through matching "SW" with "OT". As an example we present two 30-year-old patients with Marfan syndrome with identical medical history and aortic pathology. As a result of I-SWOT analysis of their individual opportunities and threats, we identified two distinct medical strategies in these patients.

CONCLUSION

I-SWOT is a formal but easy to use tool to translate medical evidence into individualized medical strategies.

摘要

背景

将证据和指南转化为针对个体患者的医疗策略是医生的任务。然而,迄今为止,尚无有助于进行这种转化的正式工具。

方法

我们引入对与治疗相关的优势(S)和劣势(W)以及与个体患者相关的机会(O)和威胁(T)的分析,作为建立个体化(I)医疗策略(I-SWOT)的工具。I-SWOT矩阵确定了四种基本策略类型。这些包括“SO”(最大化优势和机会)、“WT”(最小化劣势和威胁)、“WO”(最小化劣势和最大化机会)以及“ST”(最大化优势和最小化威胁)。每种不同的策略类型都可用于个体化医疗策略的考量。

结果

我们描述了I-SWOT的四个步骤,以建立治疗主动脉疾病的个体化医疗策略。第一步,我们确定治疗目标并识别所有基于证据的治疗选择。第二步,我们以SW矩阵形式评估每种治疗选择的优势和劣势。第三步,我们评估与个体患者相关的机会和威胁,最后一步,我们使用I-SWOT矩阵,通过将“SW”与“OT”相匹配来建立个体化医疗策略。作为示例,我们展示了两名患有相同病史和主动脉病变的30岁马凡综合征患者。通过对他们个体机会和威胁的I-SWOT分析,我们在这些患者中确定了两种不同的医疗策略。

结论

I-SWOT是一种将医学证据转化为个体化医疗策略的正式且易于使用的工具。

相似文献

1
Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).作为将证据转化为个体化医疗策略的工具的优势、劣势、机会和威胁分析(I-SWOT)。
Aorta (Stamford). 2015 Jun 1;3(3):98-107. doi: 10.12945/j.aorta.2015.14.064. eCollection 2015 Jun.
2
I-SWOT as instrument to individually optimize therapy of thoracoabdominal aortic aneurysms: Effective, norm-compliant and meeting the needs.I-SWOT作为个体化优化胸腹主动脉瘤治疗的工具:有效、符合规范且满足需求。
Gefasschirurgie. 2017;22(Suppl 1):8-16. doi: 10.1007/s00772-017-0245-z. Epub 2017 Feb 7.
3
Coronavirus disease-2019 risk management using strengths, weaknesses, opportunities, threats analysis approach in the health system: A qualitative multimethod study.运用优势、劣势、机会、威胁分析方法进行2019冠状病毒病风险管理:一项定性多方法研究
J Educ Health Promot. 2021 Dec 31;10:453. doi: 10.4103/jehp.jehp_1599_20. eCollection 2021.
4
Ranking the strategies for Indian medical tourism sector through the integration of SWOT analysis and TOPSIS method.通过整合SWOT分析和TOPSIS方法对印度医疗旅游部门的策略进行排名。
Int J Health Care Qual Assur. 2017 Oct 9;30(8):668-679. doi: 10.1108/IJHCQA-05-2016-0073.
5
Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis of Hemodialysis Electronic Health Record Implementation.血液透析电子健康记录实施的优势、劣势、机会与威胁(SWOT)分析
Cureus. 2024 Feb 22;16(2):e54675. doi: 10.7759/cureus.54675. eCollection 2024 Feb.
6
Family Medicine Program in Iran: SWOT Analysis and TOWS Matrix Model.伊朗的家庭医学项目:SWOT分析与TOWS矩阵模型
Iran J Public Health. 2019 Jun;48(6):1140-1148.
7
Intellectual property management at the National Animal Science Research Institute in India: A case study.印度国家动物科学研究所的知识产权管理:一项案例研究。
Vet World. 2019 Jul;12(7):1070-1077. doi: 10.14202/vetworld.2019.1070-1077. Epub 2019 Jul 20.
8
Exploration of conservation and development strategies with a limited stakeholder approach for local cattle breeds.以有限的利益相关者方法探索地方牛种的保护与发展策略。
Animal. 2019 Dec;13(12):2922-2931. doi: 10.1017/S1751731119001447. Epub 2019 Jun 26.
9
Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis.全球资源匮乏地区的癌症外科手术:优势、劣势、机遇和威胁分析。
Cancer. 2023 Mar 1;129(5):671-684. doi: 10.1002/cncr.34630. Epub 2023 Jan 3.
10
[A SWOT (strengths, weaknesses, opportunities, threats) analysis of the current immunization program in Zhejiang Province].[浙江省当前免疫规划的SWOT(优势、劣势、机会、威胁)分析]
Zhongguo Yi Miao He Mian Yi. 2009 Feb;15(1):65-7.

引用本文的文献

1
Applications to augment patient care for Internal Medicine specialists: a position paper from the EFIM working group on telemedicine, innovative technologies & digital health.应用于提升内科专家患者护理水平的相关研究:来自 EFIM 远程医疗、创新技术与数字健康工作组的立场文件。
Front Public Health. 2024 Jun 28;12:1370555. doi: 10.3389/fpubh.2024.1370555. eCollection 2024.
2
Analysis of the natural collapse course of non-traumatic osteonecrosis of the femoral head based on the matrix model.基于基质模型分析非创伤性股骨头坏死的自然塌陷过程。
J Orthop Surg Res. 2024 Jan 31;19(1):100. doi: 10.1186/s13018-024-04587-1.
3
Biobehavioural Physiotherapy through Telerehabilitation during the SARS-CoV-2 Pandemic in a Patient with Post-polio Syndrome and Low Back Pain: A Case Report.SARS-CoV-2大流行期间,对一名患有小儿麻痹后遗症和腰痛的患者通过远程康复进行生物行为物理治疗:病例报告
Phys Ther Res. 2021 Sep 3;24(3):295-303. doi: 10.1298/ptr.E10100. eCollection 2021.
4
Development and Validation of Prenatal Physical Activity Intervention Strategy for Women in Buffalo City Municipality, South Africa.南非布法罗市孕妇产前体育活动干预策略的制定与验证
Healthcare (Basel). 2021 Oct 26;9(11):1445. doi: 10.3390/healthcare9111445.
5
Laparoscopy in Gynecologic and Abdominal Surgery in Regional (Spinal, Peridural) Anesthesia, the Utility of the Technique during COVID-19 Pandemic.区域(脊髓、硬膜外)麻醉下妇科和腹部手术中的腹腔镜检查,该技术在COVID-19大流行期间的效用
Medicines (Basel). 2021 Oct 19;8(10):60. doi: 10.3390/medicines8100060.
6
Burden of COVID-19 on Italian Internal Medicine Wards: Delphi, SWOT, and Performance Analysis after Two Pandemic Waves in the Local Health Authority "Roma 6" Hospital Structures.COVID-19 对意大利内科病房的负担:德尔菲、SWOT 分析以及当地卫生当局“Roma 6”医院结构在两次大流行浪潮后的绩效分析。
Int J Environ Res Public Health. 2021 Jun 3;18(11):5999. doi: 10.3390/ijerph18115999.
7
Strengths-Weaknesses-Opportunities-Threats Analysis for a Pediatric Anesthesia Program.儿科麻醉项目的优势-劣势-机会-威胁分析
Pediatr Qual Saf. 2020 Jan 22;5(1):e254. doi: 10.1097/pq9.0000000000000254. eCollection 2020 Jan-Feb.
8
Strengths, weaknesses, opportunities and threats (SWOT) analysis of reinitiation into methamphetamine abusers: qualitative findings from an exploration of methamphetamine abusers in Shanghai, China.对甲基苯丙胺滥用者重新开始使用的优势、劣势、机会和威胁(SWOT)分析:来自中国上海甲基苯丙胺滥用者探索的定性研究结果
Gen Psychiatr. 2019 Jul 16;32(3):e100062. doi: 10.1136/gpsych-2019-100062. eCollection 2019.
9
Interprofessional Health Care Education at Academic Medical Centers: Using a SWOT Analysis to Develop and Implement Programming.学术医疗中心的跨专业医疗保健教育:运用SWOT分析法制定和实施相关项目。
MedEdPORTAL. 2018 Oct 19;14:10766. doi: 10.15766/mep_2374-8265.10766.
10
I-SWOT as instrument to individually optimize therapy of thoracoabdominal aortic aneurysms: Effective, norm-compliant and meeting the needs.I-SWOT作为个体化优化胸腹主动脉瘤治疗的工具:有效、符合规范且满足需求。
Gefasschirurgie. 2017;22(Suppl 1):8-16. doi: 10.1007/s00772-017-0245-z. Epub 2017 Feb 7.

本文引用的文献

1
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)主动脉疾病诊断和治疗指南:涵盖成人胸主动脉和腹主动脉急慢性疾病的文件。欧洲心脏病学会(ESC)主动脉疾病诊断和治疗特别工作组。
Eur Heart J. 2014 Nov 1;35(41):2873-926. doi: 10.1093/eurheartj/ehu281. Epub 2014 Aug 29.
2
Personalised external aortic root support (PEARS) in Marfan syndrome: analysis of 1-9 year outcomes by intention-to-treat in a cohort of the first 30 consecutive patients to receive a novel tissue and valve-conserving procedure, compared with the published results of aortic root replacement.马凡综合征的个性化外部主动脉根部支撑(PEARS):30 例连续接受新型组织和瓣膜保留手术的患者的意向治疗分析 1-9 年结果,与主动脉根部置换术的已发表结果比较。
Heart. 2014 Jun;100(12):969-75. doi: 10.1136/heartjnl-2013-304913. Epub 2014 Jan 6.
3
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.氯沙坦可降低马凡综合征成年患者的主动脉扩张速度:一项随机对照试验。
Eur Heart J. 2013 Dec;34(45):3491-500. doi: 10.1093/eurheartj/eht334. Epub 2013 Sep 2.
4
Comparison of aortic root replacement in patients with Marfan syndrome.马凡综合征患者主动脉根部置换的比较。
Eur J Cardiothorac Surg. 2011 Nov;40(5):1052-7. doi: 10.1016/j.ejcts.2011.02.018. Epub 2011 Mar 23.
5
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.加拿大心血管学会 2009 年共识会议关于成人先天性心脏病的管理:流出道梗阻、主动脉缩窄、法洛四联症、Ebstein 畸形和马凡综合征。
Can J Cardiol. 2010 Mar;26(3):e80-97. doi: 10.1016/s0828-282x(10)70355-x.
6
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.2010年美国心脏病学会基金会/美国心脏协会实践指南工作组、美国胸外科协会、美国放射学会、美国中风协会、心血管麻醉医师协会、心血管造影和介入学会、介入放射学会、胸外科医师学会以及血管医学学会关于胸主动脉疾病患者诊断和管理的指南:一份报告
Circulation. 2010 Apr 6;121(13):e266-369. doi: 10.1161/CIR.0b013e3181d4739e. Epub 2010 Mar 16.
7
Misunderstandings, misperceptions, and mistakes.误解、错误认知与失误。
Evid Based Med. 2007 Feb;12(1):2-3. doi: 10.1136/ebm.12.1.2-a.
8
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.心脏瓣膜病管理指南:欧洲心脏病学会心脏瓣膜病管理特别工作组
Eur Heart J. 2007 Jan;28(2):230-68. doi: 10.1093/eurheartj/ehl428. Epub 2007 Jan 26.
9
Guidelines for the diagnosis and management of Marfan syndrome.马凡氏综合征的诊断与管理指南。
Heart Lung Circ. 2007 Feb;16(1):28-30. doi: 10.1016/j.hlc.2006.10.022. Epub 2006 Dec 26.
10
Aortic root growth in men and women with the Marfan's syndrome.患有马凡氏综合征的男性和女性的主动脉根部生长情况。
Am J Cardiol. 2005 Nov 15;96(10):1441-4. doi: 10.1016/j.amjcard.2005.06.094. Epub 2005 Oct 5.